Nicole Germino

are you enriching for patients with higher neutrophil level or patients were a lot worse?

how are you distributing your sales force between the academic and community settings and what are the hurdles with getting prescriber uptake

Can we see some bima data this year? And do you still see some benefit with a muscle preserving drug?